Year in Review 2024 - Transformative FDA Approvals in Precision Onco…

Oncology 2024 Year in Review

V. Subbiah

Role of Surgery in Locally Advanced NSCLC

Memorial Sloan Kettering Cancer Center

K. Gray

Neoadjuvant vs. Adjuvant: A New Paradigm for NSCLC

Total Health

D. Carbone

ESMO 2024 Summary: Key Trial Insights on Managing NSCLC With Low PD-…

ecancer

L. Paz-Ares

The Use of IO Doublet in PD-L1-Negative NSCLC

David Carbone

IO Advances in Metastatic NSCLC Treatment

Fox Chase Cancer Center

H. Borghaei

EGFRm Lung Cancer: Overview & Treatment Sequence

GRACE

J. Rotow

ESMO 2024 Summary: Management of Oligoprogressive Disease - Patients…

2024 ESMO Annual Meeting Insights Hub

R. Van den Begin

Metastatic EGFRm NSCLC: 1L Therapy Options

University of Colorado Cancer Center

T. Patil

Year in Review 2024 - Top Clinical Trials in Neuro-Oncology

Oncology 2024 Year in Review

S. Bagley

Unresectable Stage 3 NSCLC: Patient Selection and Treatment Options

Fox Chase Cancer Center

C. Aggarwal

Year in Review 2024 - Targeted Therapy for NSCLC

Nebraska Oncology Society

J. Murray

Imaging of Precision Therapy in Lung Cancer

International Cancer Imaging Society (ICIS)

M. Nishino

Current Landscape of Neoadjuvant, Perioperative, and Adjuvant IO in …

UCLA Health

J. Lee

Multidisciplinary Panel Discussion: New Treatment Options for Surgic…

David Carbone

B. Stiles

The Efficacy of Immunotherapies for EGFRm Lung Cancer

GRACE

I. Dagogo-Jack, J. Rotow, M. Shields, A. Cooper, A. Qin

ESMO 2024 Summary: EGFRm NSCLC Panel Discussion - MARIPOSA, PAPILLON…

ecancer

I. Gil-Bazo, M. Brandão, B. Besse, E. Felip

WCLC 2024 Insights: Interstitial Lung Disease and Lung Cancer - How …

Insights from 2024 WCLC

S. Ikeda

ASCO® 2024 Lung Cancer Highlights: Top Abstracts Including BEAT-SC, …

2024 ASCO® Annual Meeting Insights Hub

B. Halmos

73 y/o Never-Smoker With Stage IV EGFRm NSCLC Presented With Progres…

PrecisCa

J. West, M. Ginsberg, S. Ramalingam, S. Force, C. Robinson